MK-801 disrupts and nicotine augments 40 Hz auditory steady state responses in the auditory cortex of the urethane-anesthetized rat

Neuropharmacology

Volumn 73, Issue , 2013, Pages 1-9

  Sivarao, Digavalli V ^a   Mikhail, Frenkel ^a   Ping, Chen ^a   Healy, Francine L ^a   Lodge, Nicholas J ^a   Robert, Zaczek ^a  

^a BRISTOL MYERS SQUIBB   (United States)

Author keywords

40 Hz; Auditory steady state response; MK801; Nicotine; NMDA; Schizophrenia

Indexed keywords

DIZOCILPINE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; NICOTINE; NICOTINIC RECEPTOR; NICOTINIC RECEPTOR ALPHA4BETA2; URETHAN;

ANIMAL EXPERIMENT; ARTICLE; AUDITORY CORTEX; AUDITORY RESPONSE; AUDITORY STEADY STATE RESPONSE; AUDITORY STIMULATION; CONTROLLED STUDY; ELECTROENCEPHALOGRAM; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; SCHIZOPHRENIA; STEADY STATE;

40 HZ; AUDITORY STEADY STATE RESPONSE; MK801; NICOTINE; NMDA; SCHIZOPHRENIA;

ACOUSTIC STIMULATION; ANESTHETICS, INTRAVENOUS; ANIMALS; AUDITORY CORTEX; BRAIN WAVES; DIHYDRO-BETA-ERYTHROIDINE; DIZOCILPINE MALEATE; EVOKED POTENTIALS, AUDITORY; EXCITATORY AMINO ACID ANTAGONISTS; MALE; NICOTINE; NICOTINIC AGONISTS; NICOTINIC ANTAGONISTS; RATS; URETHANE;

EID: 84885096044     PISSN: 00283908     EISSN: 18737064     Source Type: Journal    
DOI: 10.1016/j.neuropharm.2013.05.006     Document Type: Article

References (84)

1. Adler, L.E., Hoffer, L.D., Wiser, A., Freedman, R., 1993. Normalization of auditory physiology by cigarette smoking in schizophrenic patients. Am. J. Psychiatry. 150, 1856-1861. (Pubitemid 23356580)
2. Adler, L.E., Hoffer, L.J., Griffith, J., Waldo, M.C., Freedman, R., 1992. Normalization by nicotine of deficient auditory sensory gating in the relatives of schizophrenics. Biol. Psychiatry 32, 607-616.
3. Adler, L.E., Olincy, A., Waldo, M., Harris, J.G., Griffith, J., Stevens, K., Flach, K., Nagamoto, H., Bickford, P., Leonard, S., Freedman, R., 1998. Schizophrenia, sensory gating, and nicotinic receptors. Schizophr. Bull. 24, 189-202. (Pubitemid 28404980)
4. Aracri, P., Consonni, S., Morini, R., Perrella, M., Rodighiero, S., Amadeo, A., Becchetti, A., 2010. Tonic modulation of GABA release by nicotinic acetylcholine receptors in layer V of the murine prefrontal cortex. Cereb. Cortex 20, 1539-1555.
5. Baldeweg, T., Spence, S., Hirsch, S.R., Gruzelier, J., 1998. Gamma-band electroen-cephalographic oscillations in a patient with somatic hallucinations. Lancet 352, 620-621. (Pubitemid 28380147)
6. Baldeweg, T., Wong, D., Stephan, K.E., 2006. Nicotinic modulation of human auditory sensory memory: evidence from mismatch negativity potentials. Int. J. Psychophysiol. 59, 49-58. (Pubitemid 43081886)
7. Brenner, C.A., Krishnan, G.P., Vohs, J.L., Ahn, W.Y., Hetrick, W.P., Morzorati, S.L., O'Donnell, B.F., 2009. Steady state responses: electrophysiological assessment of sensory function in schizophrenia. Schizophr. Bull. 35, 1065-1077.
8. Brenner, C.A., Sporns, O., Lysaker, P.H., O'Donnell, B.F., 2003. EEG synchronization to modulated auditory tones in schizophrenia, schizoaffective disorder, and schizotypal personality disorder. Am. J. Psychiatry. 160, 2238-2240. (Pubitemid 39619622)
9. Conti, G., Santarelli, R., Grassi, C., Ottaviani, F., Azzena, G.B., 1999. Auditory steady-state responses to click trains from the rat temporal cortex. Clin. Neurophysiol. 110, 62-70. (Pubitemid 29210280)
10. Coyle, J.T., 1996. The glutamatergic dysfunction hypothesis for schizophrenia. Harv. Rev. Psychiatry 3, 241-253. (Pubitemid 26058365)
11. Driesen, N.R., McCarthy, G., Bhagwagar, Z., Bloch, M., Calhoun, V., D'Souza, D.C., Gueorguieva, R., He, G., Ramachandran, R., Suckow, R.F., Anticevic, A., Morgan, P.T., Krystal, J.H., 2013. Relationship of resting brain hyperconnectivity and schizophrenia-like symptoms produced by the NMDA receptor antagonist ketamine in humans. Mol. Psychiatry, 1-6. http://dx.doi.org/10.1038/ mp.2012.194.
12. Field, J.R., Walker, A.G., Conn, P.J., 2011. Targeting glutamate synapses in schizophrenia. Trends Mol. Med. 17, 689-698.
13. Franowicz, M.N., Barth, D.S., 1995. Comparison of evoked potentials and high-frequency (gamma-band) oscillating potentials in rat auditory cortex. J. Neurophysiol. 74, 96-112.
14. Galambos, R., Makeig, S., Talmachoff, P.J., 1981. A 40-Hz auditory potential recorded from the human scalp. Proc. Natl. Acad. Sci. U. S. A. 78, 2643-2647. (Pubitemid 11067263)
15. Gandal, M.J., Edgar, J.C., Klook, K., Siegel, S.J., 2012a. Gamma synchrony: towards a translational biomarker for the treatment-resistant symptoms of schizophrenia. Neuropharmacology 62, 1504-1518.
16. Gandal, M.J., Sisti, J., Klook, K., Ortinski, P.I., Leitman, V., Liang, Y., Thieu, T., Anderson, R., Pierce, R.C., Jonak, G., Gur, R.E., Carlson, G., Siegel, S.J., 2012b. GABAB-mediated rescue of altered excitatory-inhibitory balance, gamma synchrony and behavioral deficits following constitutive NMDAR-hypofunction. Transl Psychiatry 2, e142.
17. Grunze, H.C., Rainnie, D.G., Hasselmo, M.E., Barkai, E., Hearn, E.F., McCarley, R.W., Greene, R.W., 1996. NMDA-dependent modulation of CA1 local circuit inhibition. J. Neurosci. 16, 2034-2043. (Pubitemid 26144016)
18. Gunduz-Bruce, H., 2009. The acute effects of NMDA antagonism: from the rodent to the human brain. Brain Res. Rev. 60, 279-286.
19. Hakami, T., Jones, N.C., Tolmacheva, E.A., Gaudias, J., Chaumont, J., Salzberg, M., O'Brien, T.J., Pinault, D., 2009. NMDA receptor hypofunction leads to generalized and persistent aberrant gamma oscillations independent of hyperlocomotion and the state of consciousness. PLoS One 4, e6755.
20. Hamm, J.P., Gilmore, C.S., Picchetti, N.A., Sponheim, S.R., Clementz, B.A., 2011. Abnormalities of neuronal oscillations and temporal integration to low- and high-frequency auditory stimulation in schizophrenia. Biol. Psychiatry 69, 989-996.
21. Harkrider, A.W., Champlin, C.A., 2001. Acute effect of nicotine on non-smokers: II. MLRs and 40-Hz responses. Hear. Res. 160, 89-98.
22. Herdman, A.T., Lins, O., Van Roon, P., Stapells, D.R., Scherg, M., Picton, T.W., 2002. Intracerebral sources of human auditory steady-state responses. Brain Topogr. 15, 69-86. (Pubitemid 36083113)
23. Homayoun, H., Moghaddam, B., 2007. NMDA receptor hypofunction produces opposite effects on prefrontal cortex interneurons and pyramidal neurons. J. Neurosci. 27, 11496-11500. (Pubitemid 350006886)
24. Hong, L.E., Summerfelt, A., Buchanan, R.W., O'Donnell, P., Thaker, G.K., Weiler, M.A., Lahti, A.C., 2010. Gamma and delta neural oscillations and association with clinical symptoms under subanesthetic ketamine. Neuropsychopharmacology 35, 632-640.
25. Inami, R., Kirino, E., Inoue, R., Arai, H., 2005. Transdermal nicotine administration enhances automatic auditory processing reflected by mismatch negativity. Pharmacol. Biochem. Behav. 80, 453-461. (Pubitemid 40299347)
26. Jackson, M.E., Homayoun, H., Moghaddam, B., 2004. NMDA receptor hypofunction produces concomitant firing rate potentiation and burst activity reduction in the prefrontal cortex. Proc. Natl. Acad. Sci. U. S. A. 101, 8467-8472. (Pubitemid 38736598)
27. Javitt, D.C., 2009a. Sensory processing in schizophrenia: neither simple nor intact. Schizophr. Bull. 35, 1059-1064.
28. Javitt, D.C., 2009b. When doors of perception close: bottom-up models of disrupted cognition in schizophrenia. Annu. Rev. Clin. Psychol. 5, 249-275.
29. Javitt, D.C., Zukin, S.R., 1991. Recent advances in the phencyclidine model of schizophrenia. Am. J. Psychiatry. 148, 1301-1308.
30. Kantrowitz, J.T., Javitt, D.C., 2010. N-methyl-d-aspartate (NMDA) receptor dysfunction or dysregulation: the final common pathway on the road to schizophrenia? Brain Res. Bull. 83, 108-121.
31. Kawai, H., Lazar, R., Metherate, R., 2007. Nicotinic control of axon excitability regulates thalamocortical transmission. Nat. Neurosci. 10, 1168-1175. (Pubitemid 47339954)
32. Krishnan, G.P., Hetrick, W.P., Brenner, C.A., Shekhar, A., Steffen, A.N., O'Donnell, B.F., 2009. Steady state and induced auditory gamma deficits in schizophrenia. Neuroimage 47, 1711-1719.
33. Krishnan, R.R., Fivaz, M., Kraus, M.S., Keefe, R.S., 2011. Hierarchical temporal processing deficit model of reality distortion and psychoses. Mol. Psychiatry 16, 129-144.
34. Krystal, J.H., Karper, L.P., Seibyl, J.P., Freeman, G.K., Delaney, R., Bremner, J.D., Heninger, G.R., Bowers Jr, M.B., Charney, D.S., 1994. Subanesthetic effects of the noncompetitive NMDA antagonist, ketamine, in humans. Psychotomimetic, perceptual, cognitive, and neuroendocrine responses. Arch. Gen. Psychiatry. 51, 199-214. (Pubitemid 24081509)
35. Kuwada, S., Anderson, J.S., Batra, R., Fitzpatrick, D.C., Teissier, N., D'Angelo, W.R., 2002. Sources of the scalp-recorded amplitude-modulation following response. J. Am. Acad. Audiol. 13, 188-204. (Pubitemid 34692913)
36. Kwon, J.S., O'Donnell, B.F., Wallenstein, G.V., Greene, R.W., Hirayasu, Y., Nestor, P.G., Hasselmo, M.E., Potts, G.F., Shenton, M.E., McCarley, R.W., 1999. Gamma frequency-range abnormalities to auditory stimulation in schizophrenia. Arch. Gen. Psychiatry. 56, 1001-1005. (Pubitemid 29526383)
37. Lenoir, M., Kiyatkin, E.A., 2011. Critical role of peripheral actions of intravenous nicotine in mediating its central effects. Neuropsychopharmacology 36, 2125-2138.
38. Leonard, S., Adams, C., Breese, C.R., Adler, L.E., Bickford, P., Byerley, W., Coon, H., Griffith, J.M., Miller, C., Myles-Worsley, M., Nagamoto, H.T., Rollins, Y., Stevens, K.E., Waldo, M., Freedman, R., 1996. Nicotinic receptor function in schizophrenia. Schizophr. Bull. 22, 431-445. (Pubitemid 26295346)
39. Lewis, D.A., Sweet, R.A., 2009. Schizophrenia from a neural circuitry perspective: advancing toward rational pharmacological therapies. J. Clin. Invest. 119, 706-716.
40. Light, G.A., Hsu, J.L., Hsieh, M.H., Meyer-Gomes, K., Sprock, J., Swerdlow, N.R., Braff, D.L., 2006. Gamma band oscillations reveal neural network cortical coherence dysfunction in schizophrenia patients. Biol. Psychiatry 60, 1231-1240. (Pubitemid 44693537)
41. Lisman, J., 2012. Excitation, inhibition, local oscillations, or large-scale loops: what causes the symptoms of schizophrenia? Curr. Opin. Neurobiol. 22, 537-544.
42. Luby, E.D., Cohen, B.D., Rosenbaum, G., Gottlieb, J.S., Kelley, R., 1959. Study of a new schizophrenomimetic drug; sernyl. AMA Arch. Neurol. Psychiatry 81, 363-369.
43. Luck, S.J., Mathalon, D.H., O'Donnell, B.F., Hamalainen, M.S., Spencer, K.M., Javitt, D.C., Uhlhaas, P.J., 2011. A roadmap for the development and validation of event-related potential biomarkers in schizophrenia research. Biol. Psychiatry 70, 28-34.
44. Mansvelder, H.D., Mertz, M., Role, L.W., 2009. Nicotinic modulation of synaptic transmission and plasticity in cortico-limbic circuits. Semin. Cell. Dev. Biol. 20, 432-440.
45. McCarley, R.W., Wible, C.G., Frumin, M., Hirayasu, Y., Levitt, J.J., Fischer, I.A., Shenton, M.E., 1999. MRI anatomy of schizophrenia. Biol. Psychiatry 45, 1099-1119. (Pubitemid 29236551)
46. Metherate, R., 2004. Nicotinic acetylcholine receptors in sensory cortex. Learn. Mem. 11, 50-59. (Pubitemid 38167058)
47. Metherate, R., Ashe, J.H., 1993. Nucleus basalis stimulation facilitates thalamocort-ical synaptic transmission in the rat auditory cortex. Synapse 14, 132-143. (Pubitemid 23157761)
48. Middleton, S.J., Racca, C., Cunningham, M.O., Traub, R.D., Monyer, H., Knopfel, T., Schofield, I.S., Jenkins, A., Whittington, M.A., 2008. High-frequency network oscillations in cerebellar cortex. Neuron 58, 763-774. (Pubitemid 351778465)
49. Miller, D.W., Abercrombie, E.D., 1996. Effects of MK-801 on spontaneous and amphetamine-stimulated dopamine release in striatum measured with in vivo microdialysis in awake rats. Brain Res. Bull. 40, 57-62. (Pubitemid 26129650)
50. Miwa, J.M., Freedman, R., Lester, H.A., 2011. Neural systems governed by nicotinic acetylcholine receptors: emerging hypotheses. Neuron 70, 20-33.
51. Monaghan, D.T., Cotman, C.W., 1985. Distribution of N-methyl-D-aspartate- sensitive L-[3H]glutamate-binding sites in rat brain. J. Neurosci. 5, 2909-2919. (Pubitemid 16225491)
52. Mura, E., Zappettini, S., Preda, S., Biundo, F., Lanni, C., Grilli, M., Cavallero, A., Olivero, G., Salamone, A., Govoni, S., Marchi, M., 2012. Dual effect of beta-amyloid on alpha7 and alpha4beta2 nicotinic receptors controlling the release of glutamate, aspartate and GABA in rat hippocampus. PLoS One 7, e29661.
53. Neill, J.C., Barnes, S., Cook, S., Grayson, B., Idris, N.F., McLean, S.L., Snigdha, S., Rajagopal, L., Harte, M.K., 2010. Animal models of cognitive dysfunction and negative symptoms of schizophrenia: focus on NMDA receptor antagonism. Pharmacol. Ther. 128, 419-432.
54. Oshurkova, E., Scheich, H., Brosch, M., 2008. Click train encoding in primary and non-primary auditory cortex of anesthetized macaque monkeys. Neuroscience 153, 1289-1299.
55. Pastor, M.A., Artieda, J., Arbizu, J., Marti-Climent, J.M., Penuelas, I., Masdeu, J.C., 2002. Activation of human cerebral and cerebellar cortex by auditory stimulation at 40 Hz. J. Neurosci. 22, 10501-10506. (Pubitemid 35416887)
56. Picton, T.W., John, M.S., Dimitrijevic, A., Purcell, D., 2003. Human auditory steady-state responses. Int. J. Audiol. 42, 177-219. (Pubitemid 37372669)
57. Pinault, D., 2008. N-methyl d-aspartate receptor antagonists ketamine and MK-801 induce wake-related aberrant gamma oscillations in the rat neocortex. Biol. Psychiatry 63, 730-735. (Pubitemid 351400766)
58. Plourde, G., Chartrand, D., Fiset, P., Font, S., Backman, S.B., 2003. Antagonism of sevoflurane anaesthesia by physostigmine: effects on the auditory steady-state response and bispectral index. Br. J. Anaesth. 91, 583-586. (Pubitemid 37258604)
59. Rager, G., Singer, W., 1998. The response of cat visual cortex to flicker stimuli of variable frequency. Eur. J. Neurosci. 10, 1856-1877. (Pubitemid 28327331)
60. Rass, O., Forsyth, J.K., Krishnan, G.P., Hetrick, W.P., Klaunig, M.J., Breier, A., O'Donnell, B.F., Brenner, C.A., 2012. Auditory steady state response in the schizophrenia, first-degree relatives, and schizotypal personality disorder. Schizophr. Res. 136, 143-149.
61. Rasser, P.E., Schall, U., Todd, J., Michie, P.T., Ward, P.B., Johnston, P., Helmbold, K., Case, V., Soyland, A., Tooney, P.A., Thompson, P.M., 2011. Gray matter deficits, mismatch negativity, and outcomes in schizophrenia. Schizophr. Bull. 37, 131-140.
62. Rissling, A.J., Light, G.A., 2010. Neurophysiological measures of sensory registration, stimulus discrimination, and selection in schizophrenia patients. Curr. Top. Behav. Neurosci. 4, 283-309.
63. Roach, B.J., Mathalon, D.H., 2008. Event-related EEG time-frequency analysis: an overview of measures and an analysis of early gamma band phase locking in schizophrenia. Schizophr. Bull. 34, 907-926.
64. Roopun, A.K., Cunningham, M.O., Racca, C., Alter, K., Traub, R.D., Whittington, M.A., 2008. Region-specific changes in gamma and beta2 rhythms in NMDA receptor dysfunction models of schizophrenia. Schizophr. Bull. 34, 962-973.
65. Ross, B., Herdman, A.T., Pantev, C., 2005. Stimulus induced desynchronization of human auditory 40-Hz steady-state responses. J. Neurophysiol. 94, 4082-4093. (Pubitemid 41691770)
66. Salisbury, D.F., Kuroki, N., Kasai, K., Shenton, M.E., McCarley, R.W., 2007. Progressive and interrelated functional and structural evidence of post-onset brain reduction in schizophrenia. Arch. Gen. Psychiatry. 64, 521-529. (Pubitemid 46718285)
67. Saunders, J.A., Gandal, M.J., Siegel, S.J., 2012. NMDA antagonists recreate signal-to-noise ratio and timing perturbations present in schizophrenia. Neurobiol. Dis. 46, 93-100.
68. Sebban, C., Tesolin-Decros, B., Ciprian-Ollivier, J., Perret, L., Spedding, M., 2002. Effects of phencyclidine (PCP) and MK 801 on the EEGq in the prefrontal cortex of conscious rats; antagonism by clozapine, and antagonists of AMPA-, alpha(1)-and 5-HT(2A)-receptors. Br. J. Pharmacol. 135, 65-78. (Pubitemid 34102099)
69. Shute, C.C., Lewis, P.R., 1967. The ascending cholinergic reticular system: neocor-tical, olfactory and subcortical projections. Brain 90, 497-520.
70. Silverstein, S.M., Keane, B.P., 2011. Perceptual organization impairment in schizophrenia and associated brain mechanisms: review of research from 2005 to 2010. Schizophr. Bull. 37, 690-699.
71. Spencer, K.M., Niznikiewicz, M.A., Nestor, P.G., Shenton, M.E., McCarley, R.W., 2009. Left auditory cortex gamma synchronization and auditory hallucination symptoms in schizophrenia. BMC Neurosci. 10, 85.
72. Steinmann, I., Gutschalk, A., 2011. Potential fMRI correlates of 40-Hz phase locking in primary auditory cortex, thalamus and midbrain. Neuroimage 54, 495-504.
73. Sweet, R.A., Henteleff, R.A., Zhang, W., Sampson, A.R., Lewis, D.A., 2009. Reduced dendritic spine density in auditory cortex of subjects with schizophrenia. Neuropsychopharmacology 34, 374-389.
74. Swerdlow, N.R., 2010. Integrative circuit models and their implications for the pathophysiologies and treatments of the schizophrenias. Curr. Top. Behav. Neurosci. 4, 555-583.
75. Tang, A.H., Karson, M.A., Nagode, D.A., McIntosh, J.M., Uebele, V.N., Renger, J.J., Klugmann, M., Milner, T.A., Alger, B.E., 2011. Nerve terminal nicotinic acetyl-choline receptors initiate quantal GABA release from perisomatic interneurons by activating axonal T-type (Cav3) Ca(2)(+) channels and Ca(2)(+) release from stores. J. Neurosci. 31, 13546-13561.
76. Tatsumi, R., Fujio, M., Satoh, H., Katayama, J., Takanashi, S., Hashimoto, K., Tanaka, H., 2005. Discovery of the alpha7 nicotinic acetylcholine receptor agonists. (R)-3'-(5-Chlorothiophen-2-yl)spiro-1-azabicyclo[2.2.2] octane-3,5'-[1',3']oxazoli din-2'-one as a novel, potent, selective, and orally bioavailable ligand. J. Med. Chem. 48, 2678-2686. (Pubitemid 40516457)
77. Thompson, J.C., Tzambazis, K., Stough, C., Nagata, K., Silberstein, R.B., 2000. The effects of nicotine on the 13 Hz steady-state visually evoked potential. Clin. Neurophysiol. 111, 1589-1595. (Pubitemid 30645997)
78. Tsuzuku, T., 1993. 40-Hz steady state response in awake cats after bilateral chronic lesions in auditory cortices or inferior colliculi. Auris Nasus Larynx 20, 263-274. (Pubitemid 24038271)
79. Uhlhaas, P.J., Roux, F., Rodriguez, E., Rotarska-Jagiela, A., Singer, W., 2010. Neural synchronyandthe developmentofcorticalnetworks. Trends Cogn. Sci. 14, 72-80.
80. van den Buuse, M., 2010. Modeling the positive symptoms of schizophrenia in genetically modified mice: pharmacology and methodology aspects. Schizophr. Bull. 36, 246-270.
81. Vohs, J.L., Chambers, R.A., Krishnan, G.P., O'Donnell, B.F., Berg, S., Morzorati, S.L., 2010. GABAergic modulation of the 40 Hz auditory steady-state response in a rat model of schizophrenia. Int. J. Neuro-psychopharmacol. 13, 487-497.
82. Wallace, M.N., Shackleton, T.M., Palmer, A.R., 2002. Phase-locked responses to pure tones in the primary auditory cortex. Hear. Res. 172, 160-171. (Pubitemid 35299966)
83. Winterer, G., 2010. Why do patients with schizophrenia smoke? Curr. Opin. Psychiatry 23, 112-119.
84. Yan, Q.S., Reith, M.E., Jobe, P.C., Dailey, J.W., 1997. Dizocilpine (MK-801) increases not only dopamine but also serotonin and norepinephrine transmissions in the nucleus accumbens as measured by microdialysis in freely moving rats. Brain Res. 765, 149-158. (Pubitemid 27374926)